You’ve probably seen news about the halt in vaccinations across much of Europe in the wake of questions about whether the AstraZeneca vaccine, which is the main one in Europe, might be associated with a rare clotting syndrome as a side effect. Here’s the most detailed account of the situation I’ve read, a piece by two top flight science/epidemiology journalists writing in Science.
This is a members-only article
Small Team. Big Results.
We’re proud of what our small newsroom has accomplished and it’s not hyperbole when we say that without our members, none of this would be possible.
Free memberships available for students and those experiencing financial hardship.
Already a member? SIGN IN